- ITMN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $148.9 million.
- ITMN has traded 899,845 shares today.
- ITMN is down 3.1% today.
- ITMN was up 14.4% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ITMN with the Ticky from Trade-Ideas. See the FREE profile for ITMN NOW at Trade-Ideas More details on ITMN: InterMune, Inc., a biotechnology company, focuses on the research, development, and commercialization of therapies for pulmonology and orphan fibrotic diseases in North America and Europe. Currently there are 7 analysts that rate InterMune a buy, 1 analyst rates it a sell, and 1 rates it a hold. The average volume for InterMune has been 2.0 million shares per day over the past 30 days. InterMune has a market cap of $4.9 billion and is part of the health care sector and drugs industry. The stock has a beta of 3.61 and a short float of 15.8% with 3.24 days to cover. Shares are up 253.4% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.